C J Turtle|S R Riddell|D G Maloney - JoVE Visualize

Showing results (51-60 of 120) with videos related to

Pageof 12

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999

The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targetsD M McKinney, D A Lewinsohn, S R Riddell, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1993

Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopesM A Gavin, M J Gilbert, S R Riddell, et al.

Nature Immunology|February 27, 2001

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cellsV Groh, R Rhinehart, J Randolph-Habecker, et al.

Blood|October 26, 2000

Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantationJ Storek, G Espino, M A Dawson, et al.

Blood|December 12, 2001

Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblingsF Weissinger, B M Sandmaier, D G Maloney, et al.

Journal of Virology|January 3, 2001

Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate modelC Berger, M L Huang, M Gough, et al.

Ciba Foundation Symposium|January 1, 1994

Genetic modification of T cell clones to improve the safety and efficacy of adoptive T cell therapyP D Greenberg, B Nelson, M Gilbert, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 13, 2002

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cellsC Yee, J A Thompson, D Byrd, et al.

Cell|May 20, 1994

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytesI A York, C Roop, D W Andrews, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991

T cells from tumor-immune mice nonspecifically expanded in vitro with anti-CD3 plus IL-2 retain specific function in vitro and can eradicate disseminated leukemia in vivoK D Crossland, V K Lee, W Chen, et al.

Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:

Pageof 12

Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999

The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targetsD M McKinney, D A Lewinsohn, S R Riddell, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1993

Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopesM A Gavin, M J Gilbert, S R Riddell, et al.

Nature Immunology|February 27, 2001

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cellsV Groh, R Rhinehart, J Randolph-Habecker, et al.

Blood|October 26, 2000

Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantationJ Storek, G Espino, M A Dawson, et al.

Blood|December 12, 2001

Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblingsF Weissinger, B M Sandmaier, D G Maloney, et al.

Journal of Virology|January 3, 2001

Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate modelC Berger, M L Huang, M Gough, et al.

Ciba Foundation Symposium|January 1, 1994

Genetic modification of T cell clones to improve the safety and efficacy of adoptive T cell therapyP D Greenberg, B Nelson, M Gilbert, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 13, 2002

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cellsC Yee, J A Thompson, D Byrd, et al.

Cell|May 20, 1994

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytesI A York, C Roop, D W Andrews, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991

T cells from tumor-immune mice nonspecifically expanded in vitro with anti-CD3 plus IL-2 retain specific function in vitro and can eradicate disseminated leukemia in vivoK D Crossland, V K Lee, W Chen, et al.

Pageof 12